Literature DB >> 33045523

Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.

Petra Apel1, Christophe Rousselle2, Rosa Lange3, Fatoumata Sissoko2, Marike Kolossa-Gehring3, Eva Ougier2.   

Abstract

The European Joint Program "HBM4EU" is a joint effort of 30 countries and the European Environment Agency, co-funded under the European Commission's Horizon 2020 program, for advancing and implementing human biomonitoring (HBM) on a European scale and for providing scientific evidence for chemical policy making. One important outcome will be a Europe-wide improvement and harmonization of health risk assessment following the coordinated derivation or update of health-related guidance values referring to the internal body burden. These guidance values - named HBM guidance values or HBM-GVs - can directly be compared with HBM data. They are derived within HBM4EU for priority substances identified by the HBM4EU chemicals prioritization strategy based on existing needs to answer policy relevant questions as raised by national and EU policy makers. HBM-GVs refer to both the general population and occupationally exposed adults. Reports including the detailed reasoning for the values' proposals are subjected to a consultation process within all partner countries of the consortium to reach a broad scientific consensus on the derivation approach and on the derived values. The final HBM-GVs should be applied first within the HBM4EU project, but may also be useful for regulators and risk assessors outside this project. The subsequent adoption of derived HBM-GVs at EU-level needs to be discussed and decided within the responsible EU bodies. Nevertheless, the establishment of HBM-GVs as part of HBM4EU is already a step forward in strengthening HBM-based policy efforts for public and occupational health. The strategy for deriving HBM-GVs which is based on already existing approaches from the German HBM Commission, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) as well as from the US-based scientific consultant Summit Toxicology, the allocation of a level of confidence to the derived values, and the consultation process within the project are comprehensively described to enlighten the work accomplished under the HBM4EU initiative.
Copyright © 2020 The Author(s). Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Biomarker; Body burden; HBM-GV; HBM4EU; Health-based guidance values; Human biomonitoring; Human biomonitoring guidance values; Internal exposure; Risk assessment

Mesh:

Year:  2020        PMID: 33045523     DOI: 10.1016/j.ijheh.2020.113622

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  18 in total

1.  Multibiomarker approach to assess the magnitude of occupational exposure and effects induced by a mixture of metals.

Authors:  V Lopes de Andrade; D Serrazina; M L Mateus; C Batoréu; M Aschner; A P Marreilha Dos Santos
Journal:  Toxicol Appl Pharmacol       Date:  2021-08-23       Impact factor: 4.460

Review 2.  Model systems and organisms for addressing inter- and intra-species variability in risk assessment.

Authors:  Ivan Rusyn; Weihsueh A Chiu; Fred A Wright
Journal:  Regul Toxicol Pharmacol       Date:  2022-05-28       Impact factor: 3.598

3.  Chemical Mixtures in the EU Population: Composition and Potential Risks.

Authors:  Sebastian Socianu; Stephanie K Bopp; Eva Govarts; Liese Gilles; Jurgen Buekers; Marike Kolossa-Gehring; Thomas Backhaus; Antonio Franco
Journal:  Int J Environ Res Public Health       Date:  2022-05-18       Impact factor: 4.614

4.  Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide.

Authors:  Farida Lamkarkach; Matthieu Meslin; Marike Kolossa-Gehring; Petra Apel; Robert Garnier
Journal:  Toxics       Date:  2022-05-31

Review 5.  Environmental Substances Associated with Osteoporosis-A Scoping Review.

Authors:  Hanna Elonheimo; Rosa Lange; Hanna Tolonen; Marike Kolossa-Gehring
Journal:  Int J Environ Res Public Health       Date:  2021-01-16       Impact factor: 3.390

Review 6.  Defining the Scope of Exposome Studies and Research Needs from a Multidisciplinary Perspective.

Authors:  Pei Zhang; Christopher Carlsten; Romanas Chaleckis; Kati Hanhineva; Mengna Huang; Tomohiko Isobe; Ville M Koistinen; Isabel Meister; Stefano Papazian; Kalliroi Sdougkou; Hongyu Xie; Jonathan W Martin; Stephen M Rappaport; Hiroshi Tsugawa; Douglas I Walker; Tracey J Woodruff; Robert O Wright; Craig E Wheelock
Journal:  Environ Sci Technol Lett       Date:  2021-09-07

7.  Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients-A Case Study of Benzophenone-3.

Authors:  Christophe Rousselle; Matthieu Meslin; Tamar Berman; Marjolijn Woutersen; Wieneke Bil; Jenna Wildeman; Qasim Chaudhry
Journal:  Toxics       Date:  2022-02-19

8.  Practical Opportunities to Improve the Impact of Health Risk Assessment on Environmental and Public Health Decisions.

Authors:  Tine Bizjak; Davor Kontić; Branko Kontić
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

9.  Commentary: Novel strategies and new tools to curtail the health effects of pesticides.

Authors:  Charles Benbrook; Melissa J Perry; Fiorella Belpoggi; Philip J Landrigan; Michelle Perro; Daniele Mandrioli; Michael N Antoniou; Paul Winchester; Robin Mesnage
Journal:  Environ Health       Date:  2021-08-03       Impact factor: 5.984

10.  Data Processing Thresholds for Abundance and Sparsity and Missed Biological Insights in an Untargeted Chemical Analysis of Blood Specimens for Exposomics.

Authors:  Dinesh Kumar Barupal; Sadjad Fakouri Baygi; Robert O Wright; Manish Arora
Journal:  Front Public Health       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.